ICAM-1 costimulation induces IL-2 but inhibits IL-10 production in superantigen-activated human CD4+ T cells.

Por Labuda, T, Wendt, J, Hedlund, G, Dohlsten, M
Publicado em 1998

Comparison of immune responses induced by rat RT-1 antigens presented as inserts into liposomes, as protein micelles and as intact cells.

Por Hedlund, G, Jansson, B, Sjögren, H O
Publicado em 1984

Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo.

Por Belfrage, H, Dohlsten, M, Hedlund, G, Kalland, T
Publicado em 1997

The tumour associated cell surface antigen A6H is costimulatory for human CD4+ but not CD8+ T cells.

Por Labuda, T, Parra, E, Hedlund, G, Kalland, T, Dohlsten, M
Publicado em 1997

Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding.

Por Parra, E, Varga, M, Hedlund, G, Kalland, T, Dohlsten, M
Publicado em 1997

Maximal interferon-gamma production and early synthesis of interleukin-2 by CD4+ CDw29- CD45R- p80- human T lymphocytes.

Por Hedlund, G, Dohlsten, M, Sjögren, H O, Carlsson, R
Publicado em 1989

Effect of the synthetic immunomodulator, Linomide, on experimental models of thyroiditis

Por Hutchings, P, Hedlund, G, Dawe, K, Howlett, S, Cooke, A
Publicado em 1999

In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors.

Por Sundstedt, A, Sigvardsson, M, Leanderson, T, Hedlund, G, Kalland, T, Dohlsten, M
Publicado em 1996

Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.

Por Dohlsten, M, Hedlund, G, Akerblom, E, Lando, P A, Kalland, T
Publicado em 1991

Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.

Por Dohlsten, M, Lando, P A, Hedlund, G, Trowsdale, J, Kalland, T
Publicado em 1990

Superantigens anergize cytokine production but not cytotoxicity in vivo.

Por Sundstedt, A, Dohlsten, M, Hedlund, G, Höidén, I, Björklund, M, Kalland, T
Publicado em 1994

Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.

Por Dohlsten, M, Björklund, M, Sundstedt, A, Hedlund, G, Samson, D, Kalland, T
Publicado em 1993

Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.

Por Lando, P A, Dohlsten, M, Hedlund, G, Brodin, T, Sansom, D, Kalland, T
Publicado em 1993

Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses

Por Zhu, J, Bai, F, Hedlund, G, BjÖrk, J, Bakhiet, M, Van Der Meide, P H, Link, H
Publicado em 1999

Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.

Por Dohlsten, M, Abrahmsén, L, Björk, P, Lando, P A, Hedlund, G, Forsberg, G, Brodin, T, Gascoigne, N R, Förberg, C, Lind, P
Publicado em 1994

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma

Por Shaw, D M, Connolly, N B, Patel, P M, Kilany, S, Hedlund, G, Nordle, Ö, Forsberg, G, Zweit, J, Stern, P L, Hawkins, R E
Publicado em 2007